List of Tables
Table 1. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate by Indication (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Augmentation Therapy
Table 3. Key Players of Cystic Fibrosis(CF)
Table 4. Key Players of Non-CF Bronchiectasis(NCFB)
Table 5. Key Players of Diabetes
Table 6. Key Players of Other
Table 7. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth by End Users (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Region (US$ Million), 2021–2026
Table 10. Global Alpha 1 Antitrypsin Deficiency Treatment Market Share by Region (2021–2026)
Table 11. Global Alpha 1 Antitrypsin Deficiency Treatment Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Alpha 1 Antitrypsin Deficiency Treatment Market Share by Region (2027–2032)
Table 13. Alpha 1 Antitrypsin Deficiency Treatment Market Trends
Table 14. Alpha 1 Antitrypsin Deficiency Treatment Market Drivers
Table 15. Alpha 1 Antitrypsin Deficiency Treatment Market Challenges
Table 16. Alpha 1 Antitrypsin Deficiency Treatment Market Restraints
Table 17. Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Players (US$ Million), 2021–2026
Table 18. Global Alpha 1 Antitrypsin Deficiency Treatment Market Share by Players (2021–2026)
Table 19. Global Top Alpha 1 Antitrypsin Deficiency Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Alpha 1 Antitrypsin Deficiency Treatment Revenue, 2025
Table 20. Ranking of Global Top Alpha 1 Antitrypsin Deficiency Treatment Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Alpha 1 Antitrypsin Deficiency Treatment Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Alpha 1 Antitrypsin Deficiency Treatment, Headquarters and Area Served
Table 23. Global Key Players of Alpha 1 Antitrypsin Deficiency Treatment, Products and Applications
Table 24. Global Key Players of Alpha 1 Antitrypsin Deficiency Treatment, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Indication (US$ Million), 2021–2026
Table 27. Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Indication (2021–2026)
Table 28. Global Alpha 1 Antitrypsin Deficiency Treatment Forecasted Market Size by Indication (US$ Million), 2027–2032
Table 29. Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Indication (2027–2032)
Table 30. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by End Users (US$ Million), 2021–2026
Table 31. Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by End Users (2021–2026)
Table 32. Global Alpha 1 Antitrypsin Deficiency Treatment Forecasted Market Size by End Users (US$ Million), 2027–2032
Table 33. Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by End Users (2027–2032)
Table 34. North America Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country (US$ Million), 2021–2026
Table 36. North America Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country (US$ Million), 2027–2032
Table 49. Pfizer Company Details
Table 50. Pfizer Business Overview
Table 51. Pfizer Alpha 1 Antitrypsin Deficiency Treatment Product
Table 52. Pfizer Revenue in Alpha 1 Antitrypsin Deficiency Treatment Business (US$ Million), 2021–2026
Table 53. Pfizer Recent Development
Table 54. GlaxoSmithKline Company Details
Table 55. GlaxoSmithKline Business Overview
Table 56. GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Product
Table 57. GlaxoSmithKline Revenue in Alpha 1 Antitrypsin Deficiency Treatment Business (US$ Million), 2021–2026
Table 58. GlaxoSmithKline Recent Development
Table 59. AstraZeneca Company Details
Table 60. AstraZeneca Business Overview
Table 61. AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Product
Table 62. AstraZeneca Revenue in Alpha 1 Antitrypsin Deficiency Treatment Business (US$ Million), 2021–2026
Table 63. AstraZeneca Recent Development
Table 64. Boehringer Ingelheim Company Details
Table 65. Boehringer Ingelheim Business Overview
Table 66. Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Product
Table 67. Boehringer Ingelheim Revenue in Alpha 1 Antitrypsin Deficiency Treatment Business (US$ Million), 2021–2026
Table 68. Boehringer Ingelheim Recent Development
Table 69. Teva Pharmaceutical Industries Company Details
Table 70. Teva Pharmaceutical Industries Business Overview
Table 71. Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Product
Table 72. Teva Pharmaceutical Industries Revenue in Alpha 1 Antitrypsin Deficiency Treatment Business (US$ Million), 2021–2026
Table 73. Teva Pharmaceutical Industries Recent Development
Table 74. Takeda Company Details
Table 75. Takeda Business Overview
Table 76. Takeda Alpha 1 Antitrypsin Deficiency Treatment Product
Table 77. Takeda Revenue in Alpha 1 Antitrypsin Deficiency Treatment Business (US$ Million), 2021–2026
Table 78. Takeda Recent Development
Table 79. Baxter Company Details
Table 80. Baxter Business Overview
Table 81. Baxter Alpha 1 Antitrypsin Deficiency Treatment Product
Table 82. Baxter Revenue in Alpha 1 Antitrypsin Deficiency Treatment Business (US$ Million), 2021–2026
Table 83. Baxter Recent Development
Table 84. Grifols Company Details
Table 85. Grifols Business Overview
Table 86. Grifols Alpha 1 Antitrypsin Deficiency Treatment Product
Table 87. Grifols Revenue in Alpha 1 Antitrypsin Deficiency Treatment Business (US$ Million), 2021–2026
Table 88. Grifols Recent Development
Table 89. CSL Behring Company Details
Table 90. CSL Behring Business Overview
Table 91. CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Product
Table 92. CSL Behring Revenue in Alpha 1 Antitrypsin Deficiency Treatment Business (US$ Million), 2021–2026
Table 93. CSL Behring Recent Development
Table 94. Kamada Ltd Company Details
Table 95. Kamada Ltd Business Overview
Table 96. Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Product
Table 97. Kamada Ltd Revenue in Alpha 1 Antitrypsin Deficiency Treatment Business (US$ Million), 2021–2026
Table 98. Kamada Ltd Recent Development
Table 99. Chiesi Pharmaceuticals Company Details
Table 100. Chiesi Pharmaceuticals Business Overview
Table 101. Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Product
Table 102. Chiesi Pharmaceuticals Revenue in Alpha 1 Antitrypsin Deficiency Treatment Business (US$ Million), 2021–2026
Table 103. Chiesi Pharmaceuticals Recent Development
Table 104. Kedrion Group Company Details
Table 105. Kedrion Group Business Overview
Table 106. Kedrion Group Alpha 1 Antitrypsin Deficiency Treatment Product
Table 107. Kedrion Group Revenue in Alpha 1 Antitrypsin Deficiency Treatment Business (US$ Million), 2021–2026
Table 108. Kedrion Group Recent Development
Table 109. Vertex Pharmaceuticals Company Details
Table 110. Vertex Pharmaceuticals Business Overview
Table 111. Vertex Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Product
Table 112. Vertex Pharmaceuticals Revenue in Alpha 1 Antitrypsin Deficiency Treatment Business (US$ Million), 2021–2026
Table 113. Vertex Pharmaceuticals Recent Development
Table 114. ProMetic Life Sciences Company Details
Table 115. ProMetic Life Sciences Business Overview
Table 116. ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Product
Table 117. ProMetic Life Sciences Revenue in Alpha 1 Antitrypsin Deficiency Treatment Business (US$ Million), 2021–2026
Table 118. ProMetic Life Sciences Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Alpha 1 Antitrypsin Deficiency Treatment Picture
Figure 2. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Comparison by Indication (US$ Million), 2021–2032
Figure 3. Global Alpha 1 Antitrypsin Deficiency Treatment Market Share by Indication: 2025 vs 2032
Figure 4. Augmentation Therapy Features
Figure 5. Cystic Fibrosis(CF) Features
Figure 6. Non-CF Bronchiectasis(NCFB) Features
Figure 7. Diabetes Features
Figure 8. Other Features
Figure 9. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by End Users (US$ Million), 2021–2032
Figure 10. Global Alpha 1 Antitrypsin Deficiency Treatment Market Share by End Users: 2025 vs 2032
Figure 11. COPD Case Studies
Figure 12. Cystic Fibrosis(CF) Case Studies
Figure 13. Non-CF Bronchiectasis(NCFB) Case Studies
Figure 14. Diabetes Case Studies
Figure 15. Alpha 1 Antitrypsin Deficiency Treatment Report Years Considered
Figure 16. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 17. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Alpha 1 Antitrypsin Deficiency Treatment Market Share by Region: 2025 vs 2032
Figure 19. Global Alpha 1 Antitrypsin Deficiency Treatment Market Share by Players in 2025
Figure 20. Global Alpha 1 Antitrypsin Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Alpha 1 Antitrypsin Deficiency Treatment Revenue in 2025
Figure 22. North America Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. North America Alpha 1 Antitrypsin Deficiency Treatment Market Share by Country (2021–2032)
Figure 24. United States Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Canada Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Share by Country (2021–2032)
Figure 28. Germany Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. France Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. U.K. Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Italy Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Russia Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Ireland Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Market Share by Region (2021–2032)
Figure 36. China Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Japan Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. South Korea Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. India Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Australia & New Zealand Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America Alpha 1 Antitrypsin Deficiency Treatment Market Share by Country (2021–2032)
Figure 44. Mexico Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Brazil Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Share by Country (2021–2032)
Figure 48. Israel Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Saudi Arabia Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. UAE Alpha 1 Antitrypsin Deficiency Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Pfizer Revenue Growth Rate in Alpha 1 Antitrypsin Deficiency Treatment Business (2021–2026)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Alpha 1 Antitrypsin Deficiency Treatment Business (2021–2026)
Figure 53. AstraZeneca Revenue Growth Rate in Alpha 1 Antitrypsin Deficiency Treatment Business (2021–2026)
Figure 54. Boehringer Ingelheim Revenue Growth Rate in Alpha 1 Antitrypsin Deficiency Treatment Business (2021–2026)
Figure 55. Teva Pharmaceutical Industries Revenue Growth Rate in Alpha 1 Antitrypsin Deficiency Treatment Business (2021–2026)
Figure 56. Takeda Revenue Growth Rate in Alpha 1 Antitrypsin Deficiency Treatment Business (2021–2026)
Figure 57. Baxter Revenue Growth Rate in Alpha 1 Antitrypsin Deficiency Treatment Business (2021–2026)
Figure 58. Grifols Revenue Growth Rate in Alpha 1 Antitrypsin Deficiency Treatment Business (2021–2026)
Figure 59. CSL Behring Revenue Growth Rate in Alpha 1 Antitrypsin Deficiency Treatment Business (2021–2026)
Figure 60. Kamada Ltd Revenue Growth Rate in Alpha 1 Antitrypsin Deficiency Treatment Business (2021–2026)
Figure 61. Chiesi Pharmaceuticals Revenue Growth Rate in Alpha 1 Antitrypsin Deficiency Treatment Business (2021–2026)
Figure 62. Kedrion Group Revenue Growth Rate in Alpha 1 Antitrypsin Deficiency Treatment Business (2021–2026)
Figure 63. Vertex Pharmaceuticals Revenue Growth Rate in Alpha 1 Antitrypsin Deficiency Treatment Business (2021–2026)
Figure 64. ProMetic Life Sciences Revenue Growth Rate in Alpha 1 Antitrypsin Deficiency Treatment Business (2021–2026)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
